✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
In this review, focus is placed on the more concise asymmetric and bioenzymatic synthetic approaches attempted towards the synthesis of beta-blockers (betaxolol, metoprolol, sotalol, and timolol).
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Numerous efficient synthetic methodologies have been elaborated for the synthesis of $\beta $-blockers since the introduction of propranolol (a beta-blocker) in 1968.
📊
Key Findings & Data:Numerous efficient synthetic methodologies have been elaborated for the synthesis of $\beta $-blockers since the introduction of propranolol (a beta-blocker) in 1968.
💡
Conclusion & Impact:In this review, focus is placed on the more concise asymmetric and bioenzymatic synthetic approaches attempted towards the synthesis of beta-blockers (betaxolol, metoprolol, sotalol, and timolol).
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Beta-blockers · cardiovascular activity · antiglaucoma agent
Abstract
Numerous efficient synthetic methodologies have been elaborated for the synthesis of $\beta $-blockers since the introduction of propranolol (a beta-blocker) in 1968. In this review, focus is placed on the more concise asymmetric and bioenzymatic synthetic approaches attempted towards the synthesis of beta-blockers (betaxolol, metoprolol, sotalol, and timolol).
🔖
Cite This Article
SADDIQUE, F. A., ZAHOOR, A. F., YOUSAF, M., IRFAN, M., AHMAD, M., MANSHA, A., KHAN, Z. A., NAQVI, S. A. R. (2016). Synthetic approaches towards the synthesis of beta-blockers (betaxolol, metoprolol, sotalol, and timolol). Turkish Journal of Chemistry, Cilt: 40 - Sayı: 2, 193–224. https://ajindex.com/articles/184591